Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiden

Showing results (431-440 of 978) with videos related to

Pageof 98
Sort By:
Cancer|January 22, 2010
Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancerGisele A Sarosy, Mahrukh M Hussain, Michael V Seiden, et al.
Gynecologic Oncology|December 17, 2003
Phase II trial of anastrozole in women with asymptomatic müllerian cancerMarcela G del Carmen, Arlan F Fuller, Ursula Matulonis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2001
Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptideS Roy, C I Bayly, Y Gareau, et al.
Vaccine|February 2, 2017
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodiesElizabeth Begier, David Joshua Seiden, Michael Patton, et al.
Gynecologic Oncology|June 16, 2004
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignanciesRichard T Penson, Michael V Seiden, Annekathryn Goodman, et al.
Eye & Contact Lens|February 10, 2017
The Association of Dry Eye Symptom Severity and Comorbid Insomnia in US VeteransAnat Galor, Benjamin E Seiden, Jasmine J Park, et al.
Blood|February 15, 1995
Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10R A Baiocchi, M E Ross, J C Tan, et al.
Gynecologic Oncology|June 30, 2006
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimenU A Matulonis, S Campos, C N Krasner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancerL R Duska, R Penson, J G Supko, et al.
Gynecologic Oncology|November 2, 2005
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancerMichael V Seiden, Alan N Gordon, Diane C Bodurka, et al.
Pageof 98

Showing results (431-440 of 978) with videos related to

Sort By:
Pageof 98
Cancer|January 22, 2010
Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancerGisele A Sarosy, Mahrukh M Hussain, Michael V Seiden, et al.
Gynecologic Oncology|December 17, 2003
Phase II trial of anastrozole in women with asymptomatic müllerian cancerMarcela G del Carmen, Arlan F Fuller, Ursula Matulonis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2001
Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptideS Roy, C I Bayly, Y Gareau, et al.
Vaccine|February 2, 2017
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodiesElizabeth Begier, David Joshua Seiden, Michael Patton, et al.
Gynecologic Oncology|June 16, 2004
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignanciesRichard T Penson, Michael V Seiden, Annekathryn Goodman, et al.
Eye & Contact Lens|February 10, 2017
The Association of Dry Eye Symptom Severity and Comorbid Insomnia in US VeteransAnat Galor, Benjamin E Seiden, Jasmine J Park, et al.
Blood|February 15, 1995
Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10R A Baiocchi, M E Ross, J C Tan, et al.
Gynecologic Oncology|June 30, 2006
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimenU A Matulonis, S Campos, C N Krasner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancerL R Duska, R Penson, J G Supko, et al.
Gynecologic Oncology|November 2, 2005
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancerMichael V Seiden, Alan N Gordon, Diane C Bodurka, et al.
Pageof 98